![[Internal] Newsroom thumbnail Inflammasome Therapeutics Reports 3 Month Trial Data for Its Dual Inflammasome Inhibitor in Geographic Atrophy](https://staging.pie.bantampoint.org/wp-content/uploads/sites/4/2025/01/Internal-Newsroom-thumbnail-Inflammasome-Therapeutics-Reports-3-Month-Trial-Data-for-Its-Dual-Inflammasome-Inhibitor-in-Geographic-Atrophy-579x326.png)
Inflammasome Therapeutics Reports 3-Month Trial Data for Inflammasome Inhibitor in Geographic Atrophy
Inflammasome Therapeutics Reports Topline 3-Month Trial Data for Novel Geographic Atrophy Treatment The findings revealed a significant reduction in lesion…
GA Management: A Tale of Innovation and Caution at APVRS 2024
On Day 3 of the 17th Congress of the Asia-Pacific Vitreo-Retina Society (APVRS 2024), a captivating debate unfolded, centered on…
latest posts
